Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Lantheus Holdings
LNTH
Other Research And Development Expense
Other Research And Development Expense at other companies
Celanese Corporation
CE
$0
—
Corvex
MOVE
$899K
+12.4%
TG Therapeutics
TGTX
$43.52M
+1.1%
Oshkosh
OSK
$3.2M
-52.9%
Insmed
INSM
$32.68M
+16.4%
Teradyne, Inc.
TER
$135.56M
+14.7%
Segments
By segment
See full
Reportable
$27.59M
-1.1%
Other financials
Income statement
See full
Revenue
$377.3M
+1.2%
Gross profit
$230.9M
-2.9%
Operating income
$81.3M
-20.3%
Net income
$118.4M
+62.3%
EPS (diluted)
$1.80
+76.5%
Balance sheet
See full
Cash & equivalents
$500.3M
-46.8%
Total debt
$627.9M
+1.8%
Total equity
$1.2B
+4.1%
Total assets
$2.3B
+14.2%
Cash flow
See full
Operating cash flow
$125.1M
+16.3%
CapEx
$3.2M
-63.0%
Free cash flow
$121.9M
+23.3%
Valuation
See full
Market cap
$6.76B
-26.3%
Enterprise value
$6.89B
-20.5%
P/E
24.2×
-10.2×
P/S
4.4×
-1.6×
Profitability
See full
Gross margin
60.5%
-3.6pp
Operating margin
18.8%
-10.7pp
Net margin
18%
+0.7pp
FCF margin
24.4%
-6.4pp
Returns & leverage
See full
Return on equity
23.5%
-1.7pp
Debt / equity
0.5×
0.0×
Current ratio
2.8×
-2.9×